182 related articles for article (PubMed ID: 28081025)
1. Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
Chowdhury NA; Sewatsky ML; Kim H
Am J Phys Med Rehabil; 2017 Aug; 96(8):e151-e154. PubMed ID: 28081025
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital.
Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN
Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
Jongerius PH; Rotteveel JJ; van Limbeek J; Gabreëls FJ; van Hulst K; van den Hoogen FJ
Neurology; 2004 Oct; 63(8):1371-5. PubMed ID: 15505151
[TBL] [Abstract][Full Text] [Related]
4. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
5. Safety of combined salivary gland and multilevel intramuscular onabotulinumtoxinA injections with and without ethanol in pediatric patients with cerebral palsy: A retrospective study.
Shoval H; Levin J; Friel K; Kim H
J Pediatr Rehabil Med; 2019; 12(2):189-196. PubMed ID: 31227667
[TBL] [Abstract][Full Text] [Related]
6. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.
Patel PN; Ezzo DC
Am J Health Syst Pharm; 2009 Nov; 66(22):2024-6. PubMed ID: 19890085
[TBL] [Abstract][Full Text] [Related]
8. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
[TBL] [Abstract][Full Text] [Related]
9. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
10. Sialorrhea & aspiration control - A minimally invasive strategy uncomplicated by anticholinergic drug tolerance or tachyphylaxis.
Dohar JE
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():97-101. PubMed ID: 30554718
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
12. Sialorrhea - therapeutic drug options.
Tscheng DZ
Ann Pharmacother; 2002 Nov; 36(11):1785-90. PubMed ID: 12398577
[TBL] [Abstract][Full Text] [Related]
13. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
[TBL] [Abstract][Full Text] [Related]
14. Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands.
Berweck S; Schroeder AS; Lee SH; Bigalke H; Heinen F
Dev Med Child Neurol; 2007 Jan; 49(1):62-4. PubMed ID: 17209979
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
[TBL] [Abstract][Full Text] [Related]
16. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
Vaile L; Finlay F
Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
[No Abstract] [Full Text] [Related]
17. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea.
Chan KH; Liang C; Wilson P; Higgins D; Allen GC
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943
[TBL] [Abstract][Full Text] [Related]
18. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
[TBL] [Abstract][Full Text] [Related]
19. [Drooling in neuropediatric patients].
Steffen A; Ortfeld S; Schönweiler R
Klin Padiatr; 2011 Jan; 223(1):5-9. PubMed ID: 21271513
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A as a treatment for excessive drooling in children.
Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
